These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Bongartz T; Sutton AJ; Sweeting MJ; Buchan I; Matteson EL; Montori V JAMA; 2006 May; 295(19):2275-85. PubMed ID: 16705109 [TBL] [Abstract][Full Text] [Related]
28. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493 [TBL] [Abstract][Full Text] [Related]
29. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [TBL] [Abstract][Full Text] [Related]
30. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Keystone EC; Kavanaugh AF; Sharp JT; Tannenbaum H; Hua Y; Teoh LS; Fischkoff SA; Chartash EK Arthritis Rheum; 2004 May; 50(5):1400-11. PubMed ID: 15146409 [TBL] [Abstract][Full Text] [Related]
31. Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate. Loarce-Martos J; Garrote-Corral S; Gioia F; Bachiller-Corral J Reumatol Clin (Engl Ed); 2019; 15(6):e130-e132. PubMed ID: 28958842 [TBL] [Abstract][Full Text] [Related]
32. [Cutaneous infection due to Mycobacterium chelonae during anti-TNF therapy]. Adenis-Lamarre E; Kostrzewa E; Texier-Maugein J; Doutre MS Ann Dermatol Venereol; 2009 Nov; 136(11):811-4. PubMed ID: 19917435 [TBL] [Abstract][Full Text] [Related]
33. [Interpretation of laboratory data during cryptic leishmaniasis in dog]. Gravino AE Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723 [TBL] [Abstract][Full Text] [Related]
34. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha. Richez C; Blanco P; Gin H; Schaeverbeke T Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936 [No Abstract] [Full Text] [Related]
35. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. Singh N; Sundar S PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494 [TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate. Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966 [TBL] [Abstract][Full Text] [Related]
37. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Rantapää-Dahlqvist S; Saxne T; Klareskog L Arthritis Rheum; 2009 Nov; 60(11):3180-9. PubMed ID: 19877027 [TBL] [Abstract][Full Text] [Related]
38. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Dombrecht EJ; Aerts NE; Schuerwegh AJ; Hagendorens MM; Ebo DG; Van Offel JF; Bridts CH; Stevens WJ; De Clerck LS Clin Exp Rheumatol; 2006; 24(1):31-7. PubMed ID: 16539816 [TBL] [Abstract][Full Text] [Related]
39. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis. Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471 [TBL] [Abstract][Full Text] [Related]
40. [Cutaneous leishmaniasis in rheumatoid arthritis]. Hachicha I; Sellami M; Fourati H; Akrout R; Hdiji N; Baklouti S Rev Med Interne; 2009 Jul; 30(7):609-12. PubMed ID: 19285366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]